{"id":816055,"date":"2025-02-20T17:14:01","date_gmt":"2025-02-20T22:14:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/"},"modified":"2025-02-20T17:14:01","modified_gmt":"2025-02-20T22:14:01","slug":"cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/","title":{"rendered":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwlistdisc { list-style-type: disc }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology<\/b><\/p>\n<p class=\"bwalignc\"><i>&#8212; Acquisition Propels Cosette Into One Of The Leading Companies In Women\u2019s Health and Dermatology in the U.S. &#8212;<\/i><\/p>\n<p class=\"bwalignc\"><i>&#8212; Highly Complementary Business Strengthens Cosette\u2019s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach &#8212;<\/i><\/p>\n<p class=\"bwalignc\"><i>&#8212; Utilizing Mayne Pharma\u2019s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access &#8212;<\/i><\/p>\n<p>BRIDGEWATER, N.J.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nCosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40\/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma\u2019s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction. The transaction is expected to close in the second quarter of 2025.\n<\/p>\n<p id=\"news-body-cta\">This press release features multimedia. View the full release here: <a href=\"https:\/\/www.businesswire.com\/news\/home\/20250220569463\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250220569463\/en\/<\/a><\/p>\n<div id=\"bwbodyimg\" style=\"width: 480px;float:left;padding-left:0px;padding-right:20px;padding-top:0px;padding-bottom:0px\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg\" alt=\"(Photo: Business Wire)\" \/><\/p>\n<p style=\"font-size:85%\">(Photo: Business Wire)<\/p>\n<\/div>\n<p>\n\u201cThis acquisition marks a transformational step for Cosette, adding patented, high-growth products to solidify our leadership in women\u2019s health in the U.S. and expanding our reach globally,\u201d said Apurva Saraf, President and CEO of Cosette Pharma. \u201cBy combining Cosette\u2019s strong portfolio with Mayne Pharma\u2019s proven commercial expertise, the combined company will be well positioned to further invest in innovation, portfolio expansion and better serve our patients. We look forward to a timely closing and welcoming Mayne Pharma to the Cosette family.\u201d\n<\/p>\n<p>\n\u201cJoining the Cosette team amplifies our shared mission to improve lives through innovative and accessible Women\u2019s health and dermatology medicines,\u201d said Shawn Patrick O\u2019Brien, CEO, Mayne Pharma. \u201cThis transaction represents a unique opportunity for our employees, customers, and patients. Together, we will extend the reach of important therapies, drive innovation, and improve patient access.\u201d\n<\/p>\n<p><b>Transaction Rationale<\/b><\/p>\n<ul class=\"bwlistdisc\">\n<li><b>Strengthens Cosette\u2019s dermatology and women\u2019s health businesses<br \/>\n<br \/><\/b>The combination will create a leading women\u2019s health and dermatology focused pharmaceuticals company in the U.S. with an established presence in international markets, utilizing the strengths of two industry players to drive innovation and expand access to women\u2019s health therapies.\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Expands Cosette\u2019s commercial and operational capabilities<br \/>\n<br \/><\/b>Cosette will utilize its market-leading commercial and operational capabilities, backed by its 350+ strong team and a leading portfolio of women\u2019s health and dermatology products alongside Mayne Pharma\u2019s complementary strength in these specialty areas. Mayne Pharma is backed by a 480+ strong team, including highly effective and successful sales and marketing teams in both specialties. The combined company will have two state-of-the-art FDA -approved manufacturing sites \u2013 one each in Lincolnton, North Carolina and Salisbury, South Australia \u2013 to service patients globally.\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li><b>Adds multiple sustainable and growing patent-protected products<br \/>\n<br \/><\/b>Upon close, Cosette will market 12 patent-protected products focused on women\u2019s health and dermatology, including leading brands such as VYLEESI\u00ae, INTRAROSA\u00ae, NEXTSTELLIS\u00ae, ANNOVERA\u00ae, BIJUVA\u00ae, IMVEXXY\u00ae and RHOFADE\u00ae, and several programs in clinical development.\n<\/li>\n<\/ul>\n<p><b>Terms of the Transaction<\/b><\/p>\n<p>\nThe transaction, which comprises the acquisition of 100% of Mayne Pharma\u2019s outstanding shares by way of a scheme arrangement, is expected to close in the second quarter of 2025, subject to customary closing conditions, including customary regulatory and shareholder approvals. The combined company will be privately held upon completion of the transaction. The Boards of Directors of both companies have approved the transaction and Mayne Pharma\u2019s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction in the absence of a superior proposal and subject to an independent expert concluding the scheme is in the best interests of Mayne Pharma\u2019s shareholders. Further details of the transaction are set out in Mayne Pharma\u2019s announcement to ASX, which is available at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fannouncements.asx.com.au%2Fasxpdf%2F20250221%2Fpdf%2F06frs9hcfc6v05.pdf&amp;esheet=54211306&amp;newsitemid=20250220569463&amp;lan=en-US&amp;anchor=https%3A%2F%2Fannouncements.asx.com.au%2Fasxpdf%2F20250221%2Fpdf%2F06frs9hcfc6v05.pdf&amp;index=1&amp;md5=d4c530e64ba264a62ed738661322b2f1\">https:\/\/announcements.asx.com.au\/asxpdf\/20250221\/pdf\/06frs9hcfc6v05.pdf<\/a>.\n<\/p>\n<p>\nCosette is being advised by Santander US Capital Markets LLC and UBS Investment Bank as financial advisers and Ropes &amp; Gray LLP and Corrs Chambers Westgarth as legal advisers.\n<\/p>\n<p>\nMayne Pharma is being advised by Jefferies Australia as financial adviser and Gilbert + Tobin and Arnold &amp; Porter as legal advisers.\n<\/p>\n<p><b>About Cosette Pharmaceuticals<\/b><\/p>\n<p>\nCosette Pharmaceuticals, Inc. is a U.S.-based, fully integrated pharmaceutical company with a fast-growing portfolio of products in women\u2019s health and dermatology. Cosette has a long history in quality manufacturing of complex dosage forms including topical creams, ointments, oral liquids\/solutions and suppositories. Cosette has corporate and manufacturing facilities in New Jersey and North Carolina and is supported by 350+ dedicated team members across all functional areas. Cosette is backed by Avista Healthcare Partners, a healthcare focused private equity firm, and funds managed by Hamilton Lane, a private markets investment management firm (Nasdaq: HLNE). For more information, please visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.cosettepharma.com%2F&amp;esheet=54211306&amp;newsitemid=20250220569463&amp;lan=en-US&amp;anchor=www.cosettepharma.com&amp;index=2&amp;md5=09a85b8be6e6f12558733ff3de88d1bb\">www.cosettepharma.com<\/a> or follow Cosette on <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fcosette-pharmaceuticals-inc%2F&amp;esheet=54211306&amp;newsitemid=20250220569463&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=3&amp;md5=9b19d7a93da55a18e928d77d85311cb5\">LinkedIn<\/a>.\n<\/p>\n<p>\nVYLEESI\u00ae, CLOMID\u00ae, INTRAROSA\u00ae, AMBIEN\u00ae, AMBIEN\u00ae CR, WELCHOL\u00ae, AZOR\u00ae, TRIBENZOR\u00ae, BENICAR\u00ae, BENICAR\u00ae HCT, EFFIENT\u00ae, EVOXAC\u00ae, ANUCORT-HC\u00ae, PROMETHEGAN\u00ae, and MIGERGOT\u00ae are trademarks of Cosette Pharmaceuticals, Inc.\n<\/p>\n<p><b>About Mayne Pharma<\/b><\/p>\n<p>\nMayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercializing novel pharmaceuticals, offering patients better, safe and more accessible medicines. Mayne Pharma has a 40- year track record of innovation and success in developing new oral drug delivery systems. These technologies have been successfully commercialized in numerous products that continue to be marketed around the world. To learn more about Mayne Pharma, please visit Maynepharma.com.\n<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20250220569463r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250220569463\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20250220569463\/en\/<\/a><\/span><\/p>\n<p><b><span class=\"bwuline\">Cosette Pharmaceuticals:<\/span><\/b><\/p>\n<p><b>Media:<br \/>\n<\/b><br \/><a rel=\"nofollow\" href=\"mailto:media@cosettepharma.com\">media@cosettepharma.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America New Jersey<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Health Consumer Women General Health Pharmaceutical Biotechnology<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/3\/Cosette_Mayne_Image.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">(Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/1464250\/3\/cosette_logomark_color_1800px.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388554\/3\/Mayne_Pharma_Logo.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">(Graphic: Business Wire)<\/font><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Photo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/1464251\/3\/Apurva_headshot.jpg\" alt=\"Photo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\">(Photo: Business Wire)<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology &#8212; Acquisition Propels Cosette Into One Of The Leading Companies In Women\u2019s Health and Dermatology in the U.S. &#8212; &#8212; Highly Complementary Business Strengthens Cosette\u2019s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach &#8212; &#8212; Utilizing Mayne Pharma\u2019s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access &#8212; BRIDGEWATER, N.J.&#8211;(BUSINESS WIRE)&#8211; Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40\/share for a total consideration of approximately USD $430 Million. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-816055","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology &#8212; Acquisition Propels Cosette Into One Of The Leading Companies In Women\u2019s Health and Dermatology in the U.S. &#8212; &#8212; Highly Complementary Business Strengthens Cosette\u2019s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach &#8212; &#8212; Utilizing Mayne Pharma\u2019s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access &#8212; BRIDGEWATER, N.J.&#8211;(BUSINESS WIRE)&#8211; Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40\/share for a total consideration of approximately USD $430 Million. &hellip; Continue reading &quot;Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-20T22:14:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology\",\"datePublished\":\"2025-02-20T22:14:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/\"},\"wordCount\":977,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250220569463\\\/en\\\/2388553\\\/4\\\/Cosette_Mayne_Image.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/\",\"name\":\"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250220569463\\\/en\\\/2388553\\\/4\\\/Cosette_Mayne_Image.jpg\",\"datePublished\":\"2025-02-20T22:14:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250220569463\\\/en\\\/2388553\\\/4\\\/Cosette_Mayne_Image.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250220569463\\\/en\\\/2388553\\\/4\\\/Cosette_Mayne_Image.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/","og_locale":"en_US","og_type":"article","og_title":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology - Market Newsdesk","og_description":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology &#8212; Acquisition Propels Cosette Into One Of The Leading Companies In Women\u2019s Health and Dermatology in the U.S. &#8212; &#8212; Highly Complementary Business Strengthens Cosette\u2019s Portfolio, Commercial and Manufacturing Footprint and Expands Geographic Reach &#8212; &#8212; Utilizing Mayne Pharma\u2019s Impressive Commercial and Sales Track Record to Drive Further Growth and Enhanced Patient Access &#8212; BRIDGEWATER, N.J.&#8211;(BUSINESS WIRE)&#8211; Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40\/share for a total consideration of approximately USD $430 Million. &hellip; Continue reading \"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-20T22:14:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology","datePublished":"2025-02-20T22:14:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/"},"wordCount":977,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/","name":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg","datePublished":"2025-02-20T22:14:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250220569463\/en\/2388553\/4\/Cosette_Mayne_Image.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cosette-pharmaceuticals-announces-acquisition-of-mayne-pharma-transforming-company-into-a-leader-in-womens-health-and-dermatology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women\u2019s Health and Dermatology"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=816055"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/816055\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=816055"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=816055"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=816055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}